New biomolecular methodologies in diagnosis of lung cancer;Attualità sui nuovi metodi biomolecolari nella diagnosi di neoplasie polmonari

Recenti Progressi in Medicina

Volumn 99, Issue 9, 2008, Pages 417-421

  Carpagnano, Giovanna Elisiana ^a   Palladino, Grazia Pia ^a   Gramiccioni, Claudia ^a   Spanevello, Antonio ^a   Cagnazzo, Maria Grazia ^a   Barbaro, Maria Pia Foschino ^a  

^a Universita   (Italy)

Author keywords

Exhaled breath condensate; Non small cell lung cancer; Oncogenes; Tumor suppressor; Tumorigenesis

Indexed keywords

TUMOR MARKER;

ADVANCED CANCER; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CANCER STAGING; CAUSE OF DEATH; DIAGNOSTIC PROCEDURE; DNA EXTRACTION; EARLY DIAGNOSIS; EXPIRED AIR; GENE MUTATION; HUMAN; LUNG BIOPSY; LUNG CANCER; LUNG CARCINOGENESIS; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; ONCOGENE; REVIEW; SMOKING; SMOKING CESSATION; TUMOR SUPPRESSOR GENE; ARTICLE; GENETICS; LUNG TUMOR;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MOLECULAR DIAGNOSTIC TECHNIQUES;

EID: 60749118415     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Greenlee RT, Murray T, Golden S, Wingo PA. Cancer statistics 2000. CA Cancer J Clin 2000; 50:7-30.
2. Grozio A, Catassi A, Cavalieri Z, Paleari L, Cesario A, Russo P. Nicotine, lung and cancer. Anticancer Agents Med Chem 2007; 7: 461-466
3. Duarte RL, Paschoal ME. Molecular markers in lung cancer: prognostic role and relationship to smoking. J Bras Pneumol 2006 ; 32: 56-65.
4. Tezcan H. DNA methylation in lung cancer. N Engl J Med 2008; 358: 251.
5. Xue X, Zhu YM, Woll PJ. Circulating DNA and lung cancer. Ann N Y Acad Sci 2006; 1075: 154-164
6. Yoshida Y, Kokubu A, Suzuki K, et al. Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity. Jpn J Clin Oncol 2007; 37: 907-912 (Pubitemid 351176480)
7. Keohavong P, Lan Q, Gao WM, DeMarini DM, Mass MJ, Li XM, et al. K-ras mutations in lung carcinomas from nonsmoking women exposed to unvented coal smoke in China. Lung Cancer 2003 ; 41: 21-27 (Pubitemid 36765479)
8. Landi S, Gemignani F, Monnier S, Canzian F. A database of single-nucleotide polymorphisms and a genotyping microarray for genetic epidemiology of lung cancer. Exp Lung Res 2005; 31: 223-258 (Pubitemid 40315762)
9. Grepmeier U, Dietmaier W, Merk J, Wild PJ, Obermann EC, Pfeifer M, et al. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers. Int J Oncol 2005; 27: 481-488
10. Belinsky SA, Klinge DM, Dekker JD, Smith MW, Bocklage TJ, Gilliland FD, et al. Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin Cancer Res 2005; 11: 6505-11
11. Kallioniemi OP. Biochip technologies in cancer research. Ann Med 2001; 33: 142-147
12. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 2002; 99: 12963-12968
13. Giordano TJ, Kuick R, Thomas DG, Misek DE, Vinco M, Sanders D, et al. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene 2005; 24: 6646-6656
14. Calvo A, Gonzalez-Moreno O, Yoon CY, Huh JI, Desai K, Nguyen QT, Green JE. Prostate cancer and the genomic revolution: advances using microarray analyses. Mutat Res 2005; 576: 66-79.
15. Ahrendt SA, Chow JT, Xu LH, Yang SC, Eisenberger CF, Esteller M, et al. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 1999; 9: 299-301.
16. Sen S, Reddy VG, Khanna N, Guleria R, Kapila K, Singh N. A comparative study of telomerase activity in sputum, bronchial washing and biopsy specimens of lung cancer. Lung Cancer 2001; 33: 41-49 (Pubitemid 32586778)
17. Pasrija T, Srinivasan R, Behera D, Majumdar S. Telomerase activity in sputum and telomerase and its components in biopsies of advanced lung cancer. Eur J Cancer 2007; 43: 1476-1482 (Pubitemid 46874076)
18. Carpagnano GE, Foschino-Barbaro MP, Spanevello A, Resta O, Carpagnano F, Mulé G, et al. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer. Am J Respir Crit Care Med 2008; 177: 337-341 (Pubitemid 351198378)
19. Au JS, Cho WC, Yip TT, Law SC. Proteomic approach to biomarker discovery in cancer tissue from lung adenocarcinoma among nonsmoking Chinese women in Hong Kong. Cancer Invest 2008 ; 26: 128-135
20. LinksUnsal E, Köksal D, Yurdakul AS, Atikcan S, Cinaz P. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer. Respir Med 2005; 99: 559-565 (Pubitemid 40468502)
21. LinksLi R, Todd NW, Qiu Q, Fan T, Zhao RY, Rodgers WH, et al. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res 2007; 13: 482-487 (Pubitemid 46225353)
22. Carpagnano GE, Spanevello A, Curci C, Salerno F, Palladino GP, Resta O, et al. IL-2, TNF-alpha, and leptin: local versus systemic concentrations in NSCLC patients. Oncol Res 2007; 16: 375-381
23. Carpagnano GE, Foschino-Barbaro MP, Mulé G, Resta O, Tommasi S, Mangia A, Carpagnano F, et al. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer. Am J Respir Crit Care Med 2005; 172: 738-744